Investor profile
SV Health Investors has backed 5 European tech companies across 6 funding rounds between 2021 and 2025, joining rounds totalling €377M. Most active in Healthtech. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Quell Therapeutics | UK | 1 | €138M |
| EyeBiotech | UK | 2 | €118M |
| Artios | UK | 1 | €99M |
| Perfuze | Ireland | 1 | €22M |
| Alchemab Therapeutics | UK |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Quell Therapeutics | Series B | €138M | 2021-11 |
| Artios | Series D+ | €99M | 2025-11 |
| EyeBiotech | Series A | €61M | 2023-11 |
| EyeBiotech |
| 1 |
| €0 |
| Series A |
| €57M |
| 2022-02 |
| Perfuze | Other | €22M | 2025-03 |
